Carl Decicco - Chief Scientific Officer, Foghorn Therapeutics Inc

As of February 1, 2021


Carl Decicco Net Worth

  • Net worth is estimated to be at least $2.78M
  • Owns at least 258,397 units of Foghorn Therapeutics Inc stock

Carl Decicco Compensation at Foghorn Therapeutics Inc in 2020

  • Earned a $412.000 salary
  • Received a total compensation of $1,218,464

Carl Decicco Trading

  • Largest purchase of shares was 5,500 units , worth over $88K on October 29, 2020
  • In total has made about 2 transactions over a year
  • Usually trades in February and October, with the busiest year in 2021 and 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Carl Decicco Mailing Address

  • Mailing address is 100 Binney Street Suite 610 Cambridge MA 02142 MA

Foghorn Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Adrian Gottschalk 2020 $478,950 - $1,834,007 $311,318 - $2,624,575
Adrian Gottschalk 2019 $465,000 - $642,918 $197,625 - $1,305,543
Carl Decicco, Ph.D. 2020 $412.000 - $542,224 $214,240 $50,000 $1,218,464
Carl Decicco, Ph.D. 2019 $400,000 - $1,474,337 $136,000 $60,000 $2,070,337
Michael LaCascia 2020 $59,423 $60,000 $1,869,416 - - $1,988,838
Samuel Agresta, M.D. 2020 $412,000 - $542,224 $99,573 - $1,053,797
Samuel Agresta, M.D. 2019 $116,667 $300,000 $785,607 - - $1,202,274
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1822462/000119312521178596/d105885ddef14a.htm

Foghorn Therapeutics Inc Insider Trading

  • The most recent transaction was 5,500 units bought on October 29, 2020 by Carl Decicco worth over $88K
  • In the years Foghorn Therapeutics Inc was active, insiders at Foghorn Therapeutics Inc bought an estimated value of $5M
  • The most active traders are Adrian Gottschalk, Chief Executive Officer,  Allan Reine, Chief Financial Officer,  and Carl Decicco, Chief Scientific Officer
  • Insider trading is most common in July, with the busiest year in 2021

Foghorn Therapeutics Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1